---
title: Genelife Clinical Research Pvt. Ltd. vs PPD
slug_a: genelifecr
slug_b: ppd
site: cro
review_signal_gate: closed
canonical_path: /compare/genelifecr/ppd
---

# Genelife Clinical Research Pvt. Ltd. vs PPD

Side-by-side profile data from each company listing on this directory.

## Genelife Clinical Research Pvt. Ltd.

- Profile: [/companies/genelifecr](/companies/genelifecr)

Genelife Clinical Research Pvt. Ltd. — CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.

Services: 13. Modalities: 4. Indications: 4. Locations: 4. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Vaccine

### Indications

- Oncology
- Neurology
- Cardiovascular
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)

## PPD

- Profile: [/companies/ppd](/companies/ppd)

PPD — PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.

Services: 19. Modalities: 6. Indications: 14. Locations: 9. Certifications: 0. The strongest documented coverage currently appears in services (19).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Biomarker Assays
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology
- Women's Health

### Phases

- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)